Breaking Down Silos. Building Momentum. Delivering Progress.
Arcinova combines scientific expertise with an agile, collaborative approach to drug development. Our teams support pharmaceutical and biotechnology companies in overcoming complex development challenges and progressing programmes with confidence.
As part of Quotient Sciences, customers can access Arcinova's specialist teams as a standalone partner or benefit from seamless integration with broader development, manufacturing and clinical capabilities, providing flexible support from molecule to clinic.
For customers, the advantage is simple:
- Direct access to specialist scientific expertise
- Flexible support tailored to your programme
- Reduced complexity through integrated delivery
- A clear pathway from molecule to clinic
- The confidence of working with an organisation backed by the resources and experience of Quotient Sciences
Built for Early-Stage Programmes
Arcinova is a specialist CRDMO delivering integrated drug substance and drug product services to advance early stage drug development. Combining scientific expertise, agile project delivery and regulatory insight, we help move molecules efficiently from concept to clinic. Our collaborative approach keeps customers close to the science, providing the flexibility, responsiveness and technical expertise needed to overcome development challenges with confidence.
Expert CMC Dossier Authoring to Accelerate Regulatory Approval
A robust Chemistry, Manufacturing and Controls (CMC) strategy and the delivery of a complete, regulatory ready CMC dossier are essential to securing regulatory approval and progressing safely into the clinic. No investigational product can be administered to humans without clear, defensible CMC assurance. At Arcinova, we author the CMC dossier as an integral part of our end-to-end Drug Substance and Drug Product development services. We take full ownership of IND and IMPD documentation, delivering submission ready content aligned with global regulatory expectations and first-in-human timelines.